KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 72 filers reported holding KINNATE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 127 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 127 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 127 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 127 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | +100.0% | 127 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 127 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | – | 127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|